Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Compare the effect of ginger extract and aspirin on COX-2 gene expression in colon cancer cell line HT-29

Background and aim: Colon cancer is the third most prevalent cancer in Iran. Prolonged colon inflammation is an important factor, in the development of colon cancer. Ginger has anti-inflammatory properties due to its content of [6]-gingerol and hence can play a role in the prevention of colon cancer. In this research the effects of ginger extract on reducing expression of the C...

متن کامل

Compare the effect of ginger extract and aspirin on COX-2 gene expression in colon cancer cell line HT-29

Background and aim: Colon cancer is the third most prevalent cancer in Iran. Prolonged colon inflammation is an important factor, in the development of colon cancer. Ginger has anti-inflammatory properties due to its content of [6]-gingerol and hence can play a role in the prevention of colon cancer. In this research the effects of ginger extract on reducing expression of the C...

متن کامل

compare the effect of ginger extract and aspirin on cox-2 gene expression in colon cancer cell line ht-29

background and aim: colon cancer is the third most prevalent cancer in iran. prolonged colon inflammation is an important factor, in the development of colon cancer. ginger has anti-inflammatory properties due to its content of [6]-gingerol and hence can play a role in the prevention of colon cancer. in this research the effects of ginger extract on reducing expression of the cox-2 gene in ht-2...

متن کامل

Prognostic impact of mutation profiling in patients with stage II and III colon cancer

Development of colorectal cancer (CRC) associates with accumulation of genetic mutations include the epidermal growth factor receptor (EGFR) signaling pathway. However, whether mutations in KRAS together with downstream factors BRAF, PIK3CA and NRAS impact prognosis is still unclear for stage II-III colon cancer. In the present study a total of 228 stage II-III colon cancer samples were retrosp...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: JNCI: Journal of the National Cancer Institute

سال: 2014

ISSN: 1460-2105,0027-8874

DOI: 10.1093/jnci/dju345